Stifel Financial Corp Immuno Gen, Inc. Transaction History

Stifel Financial Corp

$93.2 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$3.75 - $20.05 $63,420 - $339,085	-16,912 Reduced 59.31%	11,601 $218,000
Q1 2023 May 12, 2023	BUY	$3.67 - $4.92 $1,445 - $1,938	394 Added 1.4%	28,513 $109,000
Q4 2022 Feb 13, 2023	SELL	$4.55 - $6.31 $288,820 - $400,539	-63,477 Reduced 69.3%	28,119 $139,000
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.47 $102,314 - $147,761	-22,838 Reduced 19.96%	91,596 $438,000
Q2 2022 Aug 15, 2022	BUY	$3.15 - $5.76 $9,607 - $17,568	3,050 Added 2.74%	114,434 $516,000
Q1 2022 May 13, 2022	BUY	$4.26 - $7.48 $21,138 - $37,115	4,962 Added 4.66%	111,384 $530,000
Q4 2021 Feb 14, 2022	BUY	$4.75 - $7.5 $87,875 - $138,750	18,500 Added 21.04%	106,422 $791,000
Q3 2021 Nov 15, 2021	BUY	$5.02 - $6.59 $18,107 - $23,770	3,607 Added 4.28%	87,922 $498,000
Q2 2021 Aug 13, 2021	SELL	$5.79 - $8.6 $13,757 - $20,433	-2,376 Reduced 2.74%	84,315 $555,000
Q1 2021 May 14, 2021	SELL	$6.5 - $10.53 $65,702 - $106,437	-10,108 Reduced 10.44%	86,691 $703,000
Q4 2020 Feb 12, 2021	SELL	$3.7 - $7.66 $93,295 - $193,146	-25,215 Reduced 20.67%	96,799 $624,000
Q3 2020 Nov 16, 2020	BUY	$3.45 - $4.89 $23,284 - $33,002	6,749 Added 5.86%	122,014 $439,000
Q2 2020 Aug 14, 2020	SELL	$3.32 - $5.34 $8,203 - $13,195	-2,471 Reduced 2.1%	115,265 $530,000
Q1 2020 May 14, 2020	SELL	$2.12 - $6.8 $4,197 - $13,464	-1,980 Reduced 1.65%	117,736 $320,000
Q4 2019 Feb 13, 2020	SELL	$2.25 - $5.8 $151,951 - $391,697	-67,534 Reduced 36.07%	119,716 $538,000
Q3 2019 Nov 19, 2019	BUY	$2.22 - $3.39 $8,964 - $13,688	4,038 Added 2.2%	187,250 $370,000
Q3 2019 Nov 13, 2019	SELL	$2.22 - $3.39 $13,997 - $21,373	-6,305 Reduced 3.33%	183,212 $360,000
Q2 2019 Aug 14, 2019	BUY	$1.8 - $3.3 $107,400 - $196,901	59,667 Added 45.95%	189,517 $320,000
Q1 2019 May 14, 2019	BUY	$2.41 - $5.91 $61,944 - $151,904	25,703 Added 24.68%	129,850 $272,000
Q4 2018 Feb 13, 2019	BUY	$3.94 - $9.7 $78,752 - $193,883	19,988 Added 23.75%	104,147 $412,000
Q3 2018 Nov 13, 2018	BUY	$8.6 - $11.26 $19,874 - $26,021	2,311 Added 2.82%	84,159 $717,000
Q2 2018 Aug 14, 2018	SELL	$9.52 - $12.15 $31,206 - $39,827	-3,278 Reduced 3.85%	81,848 $721,000
Q1 2018 May 11, 2018	SELL	$6.7 - $12.95 $354,637 - $685,456	-52,931 Reduced 38.34%	85,126 $839,000
Q4 2017 Feb 14, 2018	BUY	$5.07 - $7.92 $118,465 - $185,058	23,366 Added 20.37%	138,057 $836,000
Q3 2017 Nov 13, 2017	BUY	$5.4 - $8.47 $619,331 - $971,432	114,691	114,691 $0

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account